Thompson Rubinstein Investment Management’s Novartis NVS Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$7.81M	Hold	90,648	–	–	2.51%	15
2018 Q4	$6.97M	Hold	90,648	–	–	2.57%	15
2018 Q3	$7M	Hold	90,648	–	–	2.15%	16
2018 Q2	$6.14M	Buy	90,648 +6,466	+8%	+$446K	2.05%	17
2018 Q1	$6.1M	Buy	84,182 +632	+0.8%	+$48.1K	2.08%	16
2017 Q4	$6.29M	Buy	83,550 +6,467	+8%	+$488K	2.07%	17
2017 Q3	$5.93M	Buy	77,083 +11,973	+18%	+$904K	2.07%	17
2017 Q2	$4.87M	Sell	65,110 -334	-0.5%	-$23.7K	1.79%	19
2017 Q1	$4.36M	Sell	65,444 -536	-0.8%	-$35.7K	1.58%	25
2016 Q4	$4.31M	Buy	65,980 +325	+0.5%	+$21.1K	1.6%	23
2016 Q3	$4.64M	Sell	65,655 -854	-1%	-$62.2K	1.76%	19
2016 Q2	$4.92M	Hold	66,509	–	–	1.91%	18
2016 Q1	$4.32M	Hold	66,509	–	–	1.76%	20
2015 Q4	$5.13M	Hold	66,509	–	–	2.35%	15
2015 Q3	$5.48M	Sell	66,509 -447	-0.7%	-$39.8K	2.44%	12
2015 Q2	$5.9M	Sell	66,956 -334	-0.5%	-$30.6K	2.35%	14
2015 Q1	$5.95M	Sell	67,290 -893	-1%	-$79.2K	2.33%	14
2014 Q4	$5.66M	Sell	68,183 -262	-0.4%	-$21.7K	2.17%	15
2014 Q3	$5.77M	Hold	68,445	–	–	2.27%	16
2014 Q2	$5.55M	Hold	68,445	–	–	2.09%	16
2014 Q1	$5.21M	Sell	68,445 -4,464	-6%	-$325K	2.08%	16
2013 Q4	$5.25M	Hold	72,909	–	–	2.06%	18
2013 Q3	$5.01M	Sell	72,909 -68	-0.1%	-$4.5K	2.12%	19
2013 Q2	$4.62M	Buy	+72,977	New	+$4.75M	2.08%	18

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Thompson Rubinstein Investment Management's NVS Position: Q1 2019 in Review

Thompson Rubinstein Investment Management held its Novartis (NVS) position steady in Q1 2019 at 90,648 shares worth $7.81M. The position accounts for 2.51% of the portfolio, ranked #15.

Thompson Rubinstein Investment Management first reported a position in NVS in Q2 2013 and has held it in 24 quarters since. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

Thompson Rubinstein Investment Management held 90,648 shares of Novartis worth $7.81M as of Q1 2019.
Thompson Rubinstein Investment Management left its Novartis share count unchanged in Q1 2019.
Novartis made up 2.51% of Thompson Rubinstein Investment Management's portfolio in Q1 2019, its #15 holding.
Thompson Rubinstein Investment Management first reported a position in Novartis in Q2 2013 and has held it in 24 quarters since.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2019, filed 4 Apr 2019.